Received by email:

File: EHT - News Release announcing option grant (September 2016)(01413286-2xB87D3).DOC

Emerald Health Therapeutics Announces Stock Option Grant 

VICTORIA, BC, September 28, 2016 - Emerald Health Therapeutics Inc. (TSXV: EMH) (the "Company" or "Therapeutics") anno
--->unces that it has issued an aggregate of 1,950,000 incentive stock options to various directors , officers and employe
--->es of the Company at an exercise price of $0.72 per common share for a period of five years.  The options granted to t
--->he directors will vest immediately. The options granted to the officers and the employees will vest over 36 months.

The above-mentioned options have been granted pursuant to the Company's Stock Option Plan which has been previously ap
--->proved by the Company's shareholders and the TSX Venture Exchange.
Emerald Health Therapeutics Inc. 
Emerald Health Therapeutics wholly owns Emerald Health Botanicals. Emerald Health Botanicals holds a License under the
---> Marihuana for Medical Purposes Regulations (Canada) to cultivate and sell medical cannabis out of its facility locate
--->d in Victoria, British Columbia.  It also holds a Supplemental License to produce and sell medical cannabis oils and c
--->apsules.    

ON BEHALF OF THE BOARD
"Avtar Dhillon"
Executive Chairman

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the 
--->TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: Please contact Sandy Pratt at 250-818-9838 or ir@emerald.care.




File: EHT - News Release announcing option grant (September 2016)(01413310xB87D3).PDF

    Emerald Health Therapeutics Announces Stock
                    Option Grant
VICTORIA, BC, September 28, 2016   Emerald Health Therapeutics Inc. (TSXV: EMH) (the
"Company" or "Therapeutics") announces that it has issued an aggregate of 1,950,000 incentive
stock options to various directors , officers and employees of the Company at an exercise price
of $0.72 per common share for a period of five years. The options granted to the directors will
vest immediately. The options granted to the officers and the employees will vest over 36
months.

The above-mentioned options have been granted pursuant to the Company's Stock Option Plan
which has been previously approved by the Company's shareholders and the TSX Venture
Exchange.

Emerald Health Therapeutics Inc.
Emerald Health Therapeutics wholly owns Emerald Health Botanicals. Emerald Health Botanicals
holds a License under the Marihuana for Medical Purposes Regulations (Canada) to cultivate and
sell medical cannabis out of its facility located in Victoria, British Columbia. It also holds a
Supplemental License to produce and sell medical cannabis oils and capsules.


ON BEHALF OF THE BOARD
"Avtar Dhillon"
Executive Chairman

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in
the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of
this release.


For further information: Please contact Sandy Pratt at 250-818-9838 or ir@emerald.care.




{5016-001/01413286.DOC.2}